Vitamin D reduces deposition of advanced glycation end-products in the aortic wall and systemic oxidative stress in diabetic rats

Diabetes Research and Clinical Practice

Volumn 100, Issue 2, 2013, Pages 243-249

  Salum, Erik ^a,b   Kals, Jaak ^a,b,c   Kampus, Priit ^a,b   Salum, Tiit ^b   Zilmer, Kersti ^b   Aunapuu, Marina ^a,d   Arend, Andres ^a   Eha, Jaan ^a   Zilmer, Mihkel ^a,b  

^a UNIVERSITY OF TARTU   (Estonia)

^b Faculty of Medicine   (Estonia)

^c TARTU UNIVERSITY HOSPITAL   (Estonia)

^d ESTONIAN UNIVERSITY OF LIFE SCIENCES   (Estonia)

Author keywords

Cholecalciferol; N (carboxymethyl)lysine; Oxidative stress index; Streptozotocin; Total antioxidant capacity

Indexed keywords

6 N CARBOXYMETHYLLYSINE; ADVANCED GLYCATION END PRODUCT; COLECALCIFEROL; PEROXIDE; STREPTOZOCIN; TROLOX C;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA WALL; ARTICLE; BIOACCUMULATION; BLOOD LEVEL; CARDIOVASCULAR DISEASE; COLORIMETRY; CONTROLLED STUDY; DIABETIC ANGIOPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; LIVER LEVEL; MALE; METABOLIC PARAMETERS; NONHUMAN; OXIDATIVE STRESS; OXIDATIVE STRESS INDEX; RAT; RISK REDUCTION; STREPTOZOCIN DIABETES; TOTAL ANTIOXIDANT CAPACITY; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; AORTA; DIABETES MELLITUS, EXPERIMENTAL; GLYCOSYLATION END PRODUCTS, ADVANCED; MALE; OXIDATIVE STRESS; RATS; RATS, WISTAR; VITAMIN D;

EID: 84878354375     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2013.03.008     Document Type: Article

References (37)

1. Brownlee M. Glycation products and the pathogenesis of diabetic complications. Diabetes Care 1992, 15:1835-1843.
2. Meng J., Sakata N., Takebayashi S., Asano T., Futata T., Araki N., et al. Advanced glycation end products of the Maillard reaction in aortic pepsin-insoluble and pepsin-soluble collagen from diabetic rats. Diabetes 1996, 45:1037-1043.
3. Winlove C.P., Parker K.H., Avery N.C., Bailey A.J. Interactions of elastin and aorta with sugars in vitro and their effects on biochemical and physical properties. Diabetologia 1996, 39:1131-1139.
4. Airaksinen K.E., Salmela P.I., Linnaluoto M.K., Ikäheimo M.J., Ahola K., Ryhänen L.J. Diminished arterial elasticity in diabetes: association with fluorescent advanced glycosylation end products in collagen. Cardiovasc Res 1993, 27:942-945.
5. Reddy S., Bichler J., Wells-Knecht K.J., Thorpe S.R., Baynes J.W. Nε-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins. Biochemistry 1995, 34:10872-10878.
6. McCance D.R., Dyer D.G., Dunn J.A., Bailie K.E., Thorpe S.R., Baynes J.W., et al. Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. J Clin Invest 1993, 91:2470-2478.
7. Dyer D.G., Dunn J.A., Thorpe S.R., Bailie K.E., Lyons T.J., McCance D.R., et al. Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J Clin Invest 1993, 91:2463-2469.
8. Ceriello A., Taboga C., Tonutti L., Quagliaro L., Piconi L., Bais B., et al. Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment. Circulation 2002, 106:1211-1218.
9. Kakkar R., Mantha S.V., Radhi J., Prasad K., Kalra J. Increased oxidative stress in rat liver and pancreas during progression of streptozotocin-induced diabetes. Clin Sci 1998, 94:623-632.
10. Tsai E.C., Hirsch I.B., Brunzell J.D., Chait A. Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM. Diabetes 1994, 43:1010-1014.
11. Baynes J.W. Role of oxidative stress in development of complications in diabetes. Diabetes 1991, 40:405-412.
12. Smith P.R., Thornalley P.J. Mechanism of the degradation of non-enzymatically glycated proteins under physiological conditions. Studies with the model fructosamine, Nε-(1-deoxy-d-fructos-1-yl)hippuryl-lysine. Eur J Biochem 1992, 210:729-739.
13. Hamden K., Carreau S., Jamoussi K., Miladi S., Lajmi S., Aloulou D., et al. 1α,25 dihydroxyvitamin D3: therapeutic and preventive effects against oxidative stress, hepatic, pancreatic and renal injury in alloxan-induced diabetes in rats. J Nutr Sci Vitaminol 2009, 55:215-222.
14. Wiseman H. Vitamin D is a membrane antioxidant, ability to inhibit iron-dependent lipid peroxidation in liposomes compared to cholesterol, ergosterol and tamoxifen and relevance to anticancer action. FEBS Lett 1993, 326:285-288.
15. Sardar S., Chakraborty A., Chatterjee M. Comparative effectiveness of vitamin D3 and dietary vitamin E on peroxidation of lipids and enzymes of the hepatic antioxidant system in Sprague-Dawley rats. Int J Vitam Nutr Res 1996, 66:39-45.
16. Dong J., Wong S.L., Lau C.W., Lee H.K., Ng C.F., Zhang L., et al. Calcitriol protects renovascular function in hypertension by down-regulating angiotensin II type 1 receptors and reducing oxidative stress. Eur Heart J 2012, 33:2980-2990.
17. Salum E., Kampus P., Zilmer M., Eha J., Butlin M., Avolio A.P., et al. Effect of vitamin D on aortic remodeling in streptozotocin-induced diabetes. Cardiovasc Diabetol 2012, 11:58.
18. Gardner M.D., Dryburgh F.J., Fyffe J.A., Jenkins A.S. Predictive value of derived calcium figures based on the measurement of ionised calcium. Ann Clin Biochem 1981, 18:106-109.
19. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193:265-275.
20. Harma M., Harma M., Erel O. Increased oxidative stress in patients with hydatidiform mole. Swiss Med Wkly 2003, 133:563-566.
21. Bucala R., Tracey K.J., Cerami A. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invest 1991, 87:432-438.
22. Ono Y., Aoki S., Ohnishi K., Yasuda T., Kawano K., Tsukada Y. Increased serum levels of advanced glycation end-products and diabetic complications. Diabetes Res Clin Pract 1998, 41:131-137.
23. Monnier V.M. Intervention against the Maillard reaction in vivo. Arch Biochem Biophys 2003, 419:1-15.
24. Soulis T., Thallas V., Youssef S., Gilbert R.E., McWilliam B.G., Murray-McIntosh R.P., et al. Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury. Diabetologia 1997, 40:619-628.
25. Wolff S.P. Diabetes mellitus and free radicals, Free radicals, transition metals and oxidative stress in the aetiology of diabetes mellitus and complications. Br Med Bull 1993, 49:642-652.
26. Vincent A.M., Perrone L., Sullivan K.A., Backus C., Sastry A.M., Lastoskie C., et al. Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress. Endocrinology 2007, 148:548-558.
27. Nitti M., d'Abramo C., Traverso N., Verzola D., Garibotto G., Poggi A., et al. Central role of PKCdelta in glycoxidation-dependent apoptosis of human neurons. Free Radic Biol Med 2005, 38:846-856.
28. Feillet-Coudray C., Rock E., Coudray C., Grzelkowska K., Azais-Braesco V., Dardevet D., et al. Lipid peroxidation and antioxidant status in experimental diabetes. Clin Chim Acta 1999, 284:31-43.
29. Sun F., Iwaguchi K., Shudo R., Nagaki Y., Tanaka K., Ikeda K., et al. Change in tissue concentrations of lipid hydroperoxides, vitamin C and vitamin E in rats with streptozotocin-induced diabetes. Clin Sci 1999, 96:185-190.
30. Valkonen M., Kuusi T. Spectrophotometric assay for total peroxyl radical-trapping antioxidant potential in human serum. J Lipid Res 1997, 38:823-833.
31. Santini S.A., Marra G., Giardina B., Cotroneo P., Mordente A., Martorana G.E., et al. Defective plasma antioxidant defenses and enhanced susceptibility to lipid peroxidation in uncomplicated IDDM. Diabetes 1997, 46:1853-1858.
32. Fu M.X., Requena J.R., Jenkins A.J., Lyons T.J., Baynes J.W., Thorpe S.R. The advanced glycation end product. Nε-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions. J Biol Chem 1996, 271:9982-9986.
33. Garcion E., Sindji L., Leblondel G., Brachet P., Darcy F. 1,25-dihydroxyvitamin D3 regulates the synthesis of gamma-glutamyl transpeptidase and glutathione levels in rat primary astrocytes. J Neurochem 1999, 73:859-866.
34. Riek A.E., Oh J., Sprague J.E., Timpson A., de Las Fuentes L., Bernal-Mizrachi L., et al. Vitamin D suppression of endoplasmic reticulum stress promotes an antiatherogenic monocyte/macrophage phenotype in type 2 diabetic patients. J Biol Chem 2012, 46:38482-38494.
35. Talmor Y., Golan E., Benchetrit S., Bernheim J., Klein O., Green J., et al. Calcitriol blunts the deleterious impact of advanced glycation end products on endothelial cells. Am J Physiol Renal Physiol 2008, 294:1059-1064.
36. Wagner C.L., Greer F.R., American Academy of Pediatrics Section on Breastfeeding, American Academy of Pediatrics Committee on Nutrition Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics 2008, 122:1142-1152.
37. Fu M.X., Wells-Knecht K.J., Blackledge J.A., Lyons T.J., Thorpe S.R., Baynes J.W. Glycation, glycoxidation, and cross-linking of collagen by glucose. Kinetics, mechanisms, and inhibition of late stages of the Maillard reaction. Diabetes 1994, 43:676-683.